Please join Baker Donelson shareholder and Intellectual Property Practice Group Leader W. Edward Ramage as he leads a roundtable discussion on the current status of the ACLU's legal challenge to Myriad Genetic's breast cancer gene patents, and to what extent (if any) human genes may be patentable.
This is a complimentary event and lunch will be provided.
This program has been submitted for 1.0 hour of CLE credit.